Topical transretinoids for treatment of acne and skin diseases

Details Topical transretinoids for treatment of acne and skin diseases Topical transretinoids for treatment of acne and skin diseases

1987-06-29

1989-12-05

Lone, Werren B.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

260404, 2604055, 2604105, 2604109V, 514350, 514423, 514425, 514461, 514547, 546314, 548530, 549255, 549488, 549 70, A61K 3123, C11C 302, C07D21346, C07D30702

Patent

active

048853119

ABSTRACT:
Esters and amides of 13-trans-retinoic acid are disclosed which are used for the treatment of acne and skin diseases.

REFERENCES:
patent: 2424994 (1947-08-01), Milas
patent: 2576103 (1951-11-01), Cawley et al.
patent: 2917523 (1959-12-01), Pommer et al.
patent: 2951853 (1960-09-01), Matsui
patent: 3984544 (1976-10-01), Casmer et al.
patent: 4055659 (1977-10-01), Gander et al.
patent: 4108880 (1978-08-01), Gander et al.
patent: 4190594 (1980-02-01), Gander et al.
patent: 4216224 (1980-08-01), Yu et al.
patent: 4529600 (1985-07-01), Dawson et al.
patent: 4677120 (1987-06-01), Parish et al.

Affiliated with

Also associated with

Rating

Topical transretinoids for treatment of acne and skin diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical transretinoids for treatment of acne and skin diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical transretinoids for treatment of acne and skin diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2034726